Tirzepatide, like other agents in this class, requires monitoring for dehydration and potential effects on diabetic retinopathy, particularly during rapid improvement in glucose control
Adherence, Persistence, and Patient Experience Even when patients overcome access barriers and initiate treatment, the next challenge is staying on therapy long enough to achieve meaningful and sustained outcomes
It has been suggested that the magnitude of the GLP-1 response is related to the extent of exposure of the gut mucosa to the ingested nutrient ( Reference Schirra, Katschinski and Weidmann 28 )
Test first thing in the morning and optionally before dinner to understand your daily ketone pattern
CrossRef Clinical outcomes of glucagon-like peptide-1 receptor agonist therapy in kidney transplant recipients: a systematic review and meta-analysis Mehmet Kanbay, Sama Mahmoud Abdel-Rahman, Mustafa Guldan, Lasin Ozbek, Nur I Genc, Ahmet B Ak, Adrian Covic, Hayri K Goren Clinical Kidney Journal.2026;[Epub] CrossRef DNA-based delivery of incretin receptor agonists using MYO Technology leads to durable weight loss in a diet-induced obesity model Linda Sasset, Andrew D
This delayed transit time could reduce pill effectiveness